Rexahn Pharmaceuticals Inc (REXN)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 39.85M | 1.75M | 3.67M | 11.94M | 1.69M | 1.71M |
| Operating Income | -4.94M | -4.54M | 34.21M | -6.13M | -5.39M | 6.39M | -5.43M | -7.71M |
| Pre Tax Income | -4.93M | -4.53M | 34.26M | -5.79M | -4.96M | 5.58M | -4.8M | -7.11M |
| Net Income | -4.93M | -4.53M | 33.94M | -5.79M | -4.96M | 5.56M | -4.8M | -7.11M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -4.92M | -4.53M | 34.26M | -5.79M | -4.96M | 6.84M | -4.82M | -7.11M |
| EBITDA | -4.94M | -4.54M | 34.21M | -6.13M | -5.39M | 6.39M | -5.43M | -7.71M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 589k | 39.85M | 19.05M |
| Operating Income | -16.41M | -17.36M | -20.54M | -11.22M | -19.97M | -22.71M | 18.23M | -10.56M |
| Pre Tax Income | -9.31M | -25.3M | -14.37M | -8.64M | -24.62M | -56.69M | 18.2M | -9.97M |
| Net Income | -9.31M | -25.3M | -14.37M | -8.64M | -24.62M | -56.69M | 17.89M | -9.99M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.039 | -0.797 | -0.383 | -2.149 | -2.262 | -3.008 | 0.857 | -0.441 |
| EBIT | -14.64M | -17.36M | -20.17M | -11.22M | -16.29M | -22.86M | 18.21M | -8.73M |
| EBITDA | -16.38M | -17.31M | -20.49M | -11.21M | -19.96M | -22.7M | 18.23M | -10.56M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
